Shabeesh Balan, Yoshimi Iwayama, Tetsuo Ohnishi, Mikiko Fukuda, Atsuko Shirai, Ayumi Yamada, Sara Weirich, Maren Kirstin Schuhmacher, Kalarickal Vijayan Dileep, Toshihiro Endo, et al. A loss-of-function variant in SUV39H2 identified in autism- spectrum disorder causes altered H3K9 trimethylation and dysregulation of protocadherin β-cluster genes in the developing brain. Molecular Psychiatry. 2021. 26. 12. 7550-7559
Tetsuo Ohnishi, Yuji Kiyama, Fumiko Arima-Yoshida, Mitsutaka Kadota, Tomoe Ichikawa, Kazuyuki Yamada, Akiko Watanabe, Hisako Ohba, Kaori Tanaka, Akihiro Nakaya, et al. Cooperation of LIM domain-binding 2 (LDB2) with EGR in the pathogenesis of schizophrenia. EMBO molecular medicine. 2021. 13. 4. e12574
Shabeesh Balan, Tetsuo Ohnishi, Akiko Watanabe, Hisako Ohba, Yoshimi Iwayama, Manabu Toyoshima, Tomonori Hara, Yasuko Hisano, Yuki Miyasaka, Tomoko Toyota, et al. Role of an Atypical Cadherin Gene, Cdh23 in Prepulse Inhibition, and Implication of CDH23 in Schizophrenia. Schizophrenia bulletin. 2021. 47. 4. 1190-1200
Chie Shimamoto-Mitsuyama, Akihiro Nakaya, Kayoko Esaki, Shabeesh Balan, Yoshimi Iwayama, Tetsuo Ohnishi, Motoko Maekawa, Tomoko Toyota, Brian Dean, Takeo Yoshikawa. Lipid Pathology of the Corpus Callosum in Schizophrenia and the Potential Role of Abnormal Gene Regulatory Networks with Reduced Microglial Marker Expression. Cerebral cortex (New York, N.Y. : 1991). 2021. 31. 1. 448-462
Yuina Wada, Motoko Maekawa, Tetsuo Ohnishi, Shabeesh Balan, Shigeru Matsuoka, Kazuya Iwamoto, Yoshimi Iwayama, Hisako Ohba, Akiko Watanabe, Yasuko Hisano, et al. Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia. EBioMedicine. 2020. 62. 103130-103130
城山 優治, 大西 哲生, 有馬 史子, 門田 満隆, 尾藤 晴彦, 吉川 武男, 真鍋 俊也, 奥野 浩行. Ldb2は扁桃体側核におけるArcの発現を制御することでシナプス機能と恐怖条件づけ学習を制御する(Ldb2 modulates synaptic function and fear learning by regulating Arc expression in the lateral nucleus of the amygdala). 日本生化学会大会プログラム・講演要旨集. 2021. 94回. [P-861]
